Posted on 8970
Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS), a company dedicated to developing and delivering medicines that make a meaningful difference to people affected by neurological diseases, today reported financial results for the fourth quarter and full year ended December 31, 2020, and recent corporate highlights.
“We are excited with the opportunities ahead of us, including the continued growth of GOCOVRI which is now the first and only medication approved to treat both OFF and dyskinesia motor complications in Parkinson’s disease,” said Neil F. McFarlane, Chief Executive Officer. “Bolstered by the launch of a second indication, GOCOVRI is now approved to treat approximately 400,000 to 500,000 Parkinson’s patients. The significant progress made across the business in 2020 fueled positive momentum into 2021, and we are leveraging this as we continue to successfully execute our long-term growth strate
Piper Sandler Expands Investment Banking with the Hiring of Treavor Hill
Piper Sandler Expands Investment Banking with the Hiring of Treavor Hill
Piper Sandler Companies (NYSE: PIPR), a leading investment bank, is pleased to announce the addition of Treavor Hill as a managing director within the firms investment banking group. He will focus on the automotive and commercial vehicle aftermarkets and will be based in the firms Minneapolis office. Hill has over 10 years of investment banking experience focused on the aftermarket, executing both M&A advisory and growth/buyout financings. Prior to joining Piper Sandler, Hill was a senior vice president within the automotive aftermarket investment banking group at Jefferies. Prior to that, he was a vice president within the automotive aftermarket banking group at BB&T Capital Markets. Earlier in his career, Hill held various leadership roles in the commercial real estate industry.